⚕️ Revolutionary Cancer Treatment with Exscientia 💊 - Garry Pairaudeau at SLAS EU 2023 #shorts

(50)

Exscientia 2022-11 CEO at Evercore - EXAI

(30:38)

Prix Galien USA 2022 / Best Digital Health Solution Winner, Exscientia

(2:20)

Pharmatech: The Art of AI-Driven Drug Design with Exscientia

(9:14)

Redefining Medicine Through Patient-first AI; Andrew Hopkins

(1:7:22)

Exscientia (NASDAQ: EXAI) Q2 2022 Earnings Presentation

(2:1econd)

Using AI In Drug Discovery With Andrew Hopkins

(55:4)

Founder Stories: Andrew Hopkins, Founder and CEO of Exscientia: Using AI in Drug Discovery

(55:4)

Exscientia SCRIP 01

(4:42)

WSAI 2019 - Exscientia - Impatient for patients -how and why AI can speed up the route for new...

(13:9)

Exscientia's AI Generates Sixth Clinical-Stage Molecule - DSP-2342, a dual 5-HT2A/5-HT7 antagonist

(1:13)

Employer Brand Breakdown: Behind the Success of Exscientia

(18:50)

Frontier IP says market uncertainty behind Exscientia disposal

(8:52)

Can AI Design Drugs? - Aleksandra Kalisz (Exscientia)

(55:41)

CQDM AI 3rd Webinar: The Evolving Landscape of AI Implementation in New Drug Discovery \u0026 Development

(1:28:56)

Prix Galien UK 2023 / Best Digital Health Solution winner, Exscientia

(1:39)

Exscientia EXAI Q1 2023 Earnings Call \u0026 Presentation

(42:)

Frontier IP Group present in-depth update on portfolio progression, hailing Exscientia IPO success

(12:1econd)

AI Drug Discovery Is the Next Trillion-Dollar Industry

(26:21)

Embracing Automation in the Pharmaceutical Industry - Garry Pairaudeau at SLAS EU 2023 #shorts

(46)